The present study examines a modified version of the murine ear dermis Mtb infection model in conjunction with IL-2/anti-IL-2 complex treatment as a model for host-directed immunotherapy to specifically boost and activate NK cells and CD8+ memory T cells during progression to active TB as a consequence of CD4+ T cell deficiency. This evidence concerns the gene IL2 and congenital T-cell immunodeficiency.